Abstract
In the title compound, C8H7N3O2S, the dihedral angle between the thiazol and isoxazole rings is 34.08 (13)°. In the crystal, the molecules are linked by pairs of N—H⋯N hydrogen bonds, forming inversion dimers, and C—H⋯O interactions, resulting in chains along the b-axis direction.
Related literature
For background to isoxazole-containing drugs, see: Shaw et al. (2011 ▶); Schattenkirchner (2000 ▶); Huang et al. (2003 ▶). For the crystal structure of a related compound, see: Wang et al. (2011 ▶).
Experimental
Crystal data
C8H7N3O2S
M r = 209.23
Monoclinic,
a = 8.8460 (18) Å
b = 10.742 (2) Å
c = 10.024 (2) Å
β = 107.27 (3)°
V = 909.6 (3) Å3
Z = 4
Mo Kα radiation
μ = 0.33 mm−1
T = 293 K
0.30 × 0.20 × 0.10 mm
Data collection
Enraf–Nonius CAD-4 diffractometer
Absorption correction: ψ scan (North et al., 1968 ▶) T min = 0.907, T max = 0.968
3462 measured reflections
1676 independent reflections
1298 reflections with I > 2σ(I)
R int = 0.060
3 standard reflections every 200 reflections intensity decay: 1%
Refinement
R[F 2 > 2σ(F 2)] = 0.051
wR(F 2) = 0.152
S = 1.00
1676 reflections
128 parameters
H-atom parameters constrained
Δρmax = 0.38 e Å−3
Δρmin = −0.34 e Å−3
Data collection: CAD-4 EXPRESS (Enraf–Nonius,1994) ▶; cell refinement: CAD-4 EXPRESS; data reduction: XCAD4 (Harms & Wocadlo,1995 ▶); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: SHELXTL (Sheldrick, 2008 ▶); software used to prepare material for publication: PLATON (Spek, 2009 ▶).
Supplementary Material
Crystal structure: contains datablock(s) I, New_Global_Publ_Block. DOI: 10.1107/S1600536813012105/pv2631sup1.cif
Structure factors: contains datablock(s) I. DOI: 10.1107/S1600536813012105/pv2631Isup2.hkl
Supplementary material file. DOI: 10.1107/S1600536813012105/pv2631Isup3.cml
Additional supplementary materials: crystallographic information; 3D view; checkCIF report
Table 1. Hydrogen-bond geometry (Å, °).
| D—H⋯A | D—H | H⋯A | D⋯A | D—H⋯A |
|---|---|---|---|---|
| N2—H2A⋯N1i | 0.86 | 2.14 | 2.970 (3) | 162 |
| C6—H6A⋯O1ii | 0.93 | 2.36 | 3.287 (4) | 171 |
Symmetry codes: (i)
; (ii)
.
supplementary crystallographic information
Comment
Leflunomide is one of the most effective isoxazole-containing disease-modifying drugs for treating rheumatoid arthritis (Shaw et al., 2011; Schattenkirchner, 2000). Many leflunomide analogs have been synthesized which exhibit potent immunomodulating effect (Huang et al., 2003). In our previous work, some anolog has been sucessfully sythesized (Wang et al., 2011). A new leflunomide analog, N-5-methyl-N-(thiazol-2-yl)isoxazole-4-carboxamide, was synthesized in our laboratory as a novel and potent immunomodulating drug. In this paper we report its crystal structure.
The bond distances and angles in the title compound (Fig. 1) agree very well with the corresponding bond distances and angles reported in a closely related compound (Wang et al., 2011). The dihedral angle between the C1/C2/N1/C3/S thiazol ring and the C5/C6/N3/O2/C7 isoxazole ring is 34.08 (13) °. In the crystal, the molecules are linked by N—H···N hydrogen bonds forming diamers about inversion centers and C—H···O hydrogen bonding interactions resulting in chains lying along the b-axis (Tab. 1 & Fig. 2).
Experimental
A solution of 5-methylisoxazole-4-carboxylic acid chloride (7.3 g, 0.05 mol) in acetonitrile (20 ml) was added dropwise, while stirring, to thiazol-2-amine (12.9 g, 0.10 mol) dissolved in acetonitrile (150 ml), at room temperature. After stirring for 40 more minutes, the precipitated 5-methyl-N-(thiazol-2-yl)isoxazole-4-carboxamide was filtered off and washed with 100 ml portions of acetonitrile, and the combined filtrates were concentrated under reduced pressure yielded the title compouind as yellow crytalline product(Yield: 8.2 g; 60%). Crystals suitable for X-ray diffraction were obtained by slow evaporation of toluene solution.
Refinement
All H atoms were placed geometrically at the distances of 0.93–0.96 Å for C—H and 0.86 Å for N—H and included in the refinement in riding motion approximation with Uiso(H) = 1.2 or 1.5Ueq of the carrier atom.
Figures
Fig. 1.
The molecular structure of the title compound with the atom numbering scheme. Displacement ellipsoids are drawn at the 35% probability level. H atoms are presented as small spheres of arbitrary radius.
Fig. 2.

A view of the N—H···N and C—H···O hydrogen bonds (dotted lines) in the crystal structure of the title compound. H atoms non-participating in hydrogen-bonding were omitted for clarity.
Crystal data
| C8H7N3O2S | F(000) = 432 |
| Mr = 209.23 | Dx = 1.528 Mg m−3 |
| Monoclinic, P21/c | Mo Kα radiation, λ = 0.71073 Å |
| Hall symbol: -P 2ybc | Cell parameters from 25 reflections |
| a = 8.8460 (18) Å | θ = 10–13° |
| b = 10.742 (2) Å | µ = 0.33 mm−1 |
| c = 10.024 (2) Å | T = 293 K |
| β = 107.27 (3)° | Block, yellow |
| V = 909.6 (3) Å3 | 0.30 × 0.20 × 0.10 mm |
| Z = 4 |
Data collection
| Enraf–Nonius CAD-4 diffractometer | 1298 reflections with I > 2σ(I) |
| Radiation source: fine-focus sealed tube | Rint = 0.060 |
| Graphite monochromator | θmax = 25.4°, θmin = 2.4° |
| ω/2θ scans | h = 0→10 |
| Absorption correction: ψ scan (North et al., 1968) | k = −12→12 |
| Tmin = 0.907, Tmax = 0.968 | l = −12→11 |
| 3462 measured reflections | 3 standard reflections every 200 reflections |
| 1676 independent reflections | intensity decay: 1% |
Refinement
| Refinement on F2 | Secondary atom site location: difference Fourier map |
| Least-squares matrix: full | Hydrogen site location: inferred from neighbouring sites |
| R[F2 > 2σ(F2)] = 0.051 | H-atom parameters constrained |
| wR(F2) = 0.152 | w = 1/[σ2(Fo2) + (0.1P)2 + 0.180P] where P = (Fo2 + 2Fc2)/3 |
| S = 1.00 | (Δ/σ)max < 0.001 |
| 1676 reflections | Δρmax = 0.38 e Å−3 |
| 128 parameters | Δρmin = −0.34 e Å−3 |
| 0 restraints | Extinction correction: SHELXL, Fc*=kFc[1+0.001xFc2λ3/sin(2θ)]-1/4 |
| Primary atom site location: structure-invariant direct methods | Extinction coefficient: 0.021 (5) |
Special details
| Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes. |
| Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger. |
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)
| x | y | z | Uiso*/Ueq | ||
| S | 0.27245 (9) | 0.30807 (7) | 0.46506 (9) | 0.0578 (3) | |
| O1 | 0.5024 (2) | 0.36916 (17) | 0.3546 (2) | 0.0517 (6) | |
| N1 | 0.3255 (3) | 0.0745 (2) | 0.5154 (2) | 0.0463 (6) | |
| C1 | 0.1512 (4) | 0.2266 (3) | 0.5378 (4) | 0.0629 (9) | |
| H1A | 0.0654 | 0.2605 | 0.5607 | 0.075* | |
| O2 | 0.8730 (2) | 0.2660 (2) | 0.1941 (2) | 0.0532 (6) | |
| N2 | 0.5011 (2) | 0.16438 (19) | 0.4088 (2) | 0.0390 (5) | |
| H2A | 0.5475 | 0.0938 | 0.4106 | 0.047* | |
| C2 | 0.1958 (3) | 0.1078 (3) | 0.5573 (3) | 0.0558 (8) | |
| H2B | 0.1426 | 0.0507 | 0.5969 | 0.067* | |
| N3 | 0.8148 (3) | 0.1439 (3) | 0.1552 (3) | 0.0569 (7) | |
| C3 | 0.3761 (3) | 0.1719 (2) | 0.4640 (3) | 0.0371 (6) | |
| C4 | 0.5547 (3) | 0.2644 (2) | 0.3512 (3) | 0.0358 (5) | |
| C5 | 0.6762 (3) | 0.2373 (2) | 0.2825 (2) | 0.0349 (5) | |
| C6 | 0.6993 (3) | 0.1306 (3) | 0.2088 (3) | 0.0459 (6) | |
| H6A | 0.6384 | 0.0587 | 0.1998 | 0.055* | |
| C7 | 0.7873 (3) | 0.3192 (2) | 0.2679 (3) | 0.0395 (6) | |
| C8 | 0.8309 (4) | 0.4479 (3) | 0.3178 (3) | 0.0546 (7) | |
| H8A | 0.9169 | 0.4761 | 0.2855 | 0.082* | |
| H8B | 0.8626 | 0.4493 | 0.4180 | 0.082* | |
| H8C | 0.7413 | 0.5018 | 0.2821 | 0.082* |
Atomic displacement parameters (Å2)
| U11 | U22 | U33 | U12 | U13 | U23 | |
| S | 0.0540 (5) | 0.0548 (5) | 0.0796 (6) | 0.0179 (3) | 0.0427 (4) | 0.0136 (4) |
| O1 | 0.0510 (12) | 0.0391 (10) | 0.0740 (14) | 0.0077 (8) | 0.0325 (10) | 0.0069 (9) |
| N1 | 0.0408 (12) | 0.0511 (13) | 0.0544 (13) | 0.0009 (10) | 0.0255 (10) | 0.0066 (11) |
| C1 | 0.0458 (17) | 0.081 (2) | 0.076 (2) | 0.0194 (16) | 0.0384 (16) | 0.0196 (18) |
| O2 | 0.0447 (11) | 0.0687 (13) | 0.0561 (12) | −0.0065 (9) | 0.0302 (9) | −0.0037 (10) |
| N2 | 0.0395 (11) | 0.0359 (10) | 0.0499 (12) | 0.0032 (9) | 0.0260 (10) | 0.0014 (9) |
| C2 | 0.0403 (15) | 0.076 (2) | 0.0595 (17) | 0.0020 (14) | 0.0282 (13) | 0.0169 (15) |
| N3 | 0.0598 (15) | 0.0630 (15) | 0.0570 (15) | 0.0005 (13) | 0.0312 (12) | −0.0131 (12) |
| C3 | 0.0320 (12) | 0.0434 (14) | 0.0378 (13) | 0.0024 (10) | 0.0133 (10) | −0.0014 (10) |
| C4 | 0.0314 (12) | 0.0372 (12) | 0.0410 (13) | 0.0014 (10) | 0.0144 (10) | −0.0008 (10) |
| C5 | 0.0329 (12) | 0.0382 (13) | 0.0356 (12) | 0.0004 (10) | 0.0132 (10) | 0.0014 (10) |
| C6 | 0.0498 (15) | 0.0436 (14) | 0.0482 (15) | −0.0031 (12) | 0.0207 (12) | −0.0060 (12) |
| C7 | 0.0358 (13) | 0.0501 (15) | 0.0351 (13) | 0.0006 (11) | 0.0143 (11) | 0.0039 (10) |
| C8 | 0.0531 (17) | 0.0512 (16) | 0.0616 (18) | −0.0123 (13) | 0.0203 (14) | 0.0034 (14) |
Geometric parameters (Å, º)
| S—C1 | 1.707 (3) | N2—H2A | 0.8600 |
| S—C3 | 1.729 (2) | C2—H2B | 0.9300 |
| O1—C4 | 1.222 (3) | N3—C6 | 1.296 (4) |
| N1—C3 | 1.303 (3) | C4—C5 | 1.468 (3) |
| N1—C2 | 1.381 (3) | C5—C7 | 1.358 (4) |
| C1—C2 | 1.332 (5) | C5—C6 | 1.411 (4) |
| C1—H1A | 0.9300 | C6—H6A | 0.9300 |
| O2—C7 | 1.334 (3) | C7—C8 | 1.483 (4) |
| O2—N3 | 1.420 (3) | C8—H8A | 0.9600 |
| N2—C4 | 1.369 (3) | C8—H8B | 0.9600 |
| N2—C3 | 1.377 (3) | C8—H8C | 0.9600 |
| C1—S—C3 | 88.31 (14) | O1—C4—C5 | 122.1 (2) |
| C3—N1—C2 | 109.1 (2) | N2—C4—C5 | 115.9 (2) |
| C2—C1—S | 111.0 (2) | C7—C5—C6 | 104.4 (2) |
| C2—C1—H1A | 124.5 | C7—C5—C4 | 125.2 (2) |
| S—C1—H1A | 124.5 | C6—C5—C4 | 130.3 (2) |
| C7—O2—N3 | 109.2 (2) | N3—C6—C5 | 112.4 (3) |
| C4—N2—C3 | 122.9 (2) | N3—C6—H6A | 123.8 |
| C4—N2—H2A | 118.5 | C5—C6—H6A | 123.8 |
| C3—N2—H2A | 118.5 | O2—C7—C5 | 109.3 (2) |
| C1—C2—N1 | 116.1 (3) | O2—C7—C8 | 117.0 (2) |
| C1—C2—H2B | 122.0 | C5—C7—C8 | 133.7 (3) |
| N1—C2—H2B | 122.0 | C7—C8—H8A | 109.5 |
| C6—N3—O2 | 104.7 (2) | C7—C8—H8B | 109.5 |
| N1—C3—N2 | 121.6 (2) | H8A—C8—H8B | 109.5 |
| N1—C3—S | 115.55 (19) | C7—C8—H8C | 109.5 |
| N2—C3—S | 122.86 (19) | H8A—C8—H8C | 109.5 |
| O1—C4—N2 | 122.0 (2) | H8B—C8—H8C | 109.5 |
| C3—S—C1—C2 | 0.8 (3) | N2—C4—C5—C7 | −152.8 (2) |
| S—C1—C2—N1 | −0.6 (4) | O1—C4—C5—C6 | −145.8 (3) |
| C3—N1—C2—C1 | −0.1 (4) | N2—C4—C5—C6 | 32.8 (4) |
| C7—O2—N3—C6 | −0.6 (3) | O2—N3—C6—C5 | −0.1 (3) |
| C2—N1—C3—N2 | −177.4 (2) | C7—C5—C6—N3 | 0.8 (3) |
| C2—N1—C3—S | 0.7 (3) | C4—C5—C6—N3 | 176.1 (3) |
| C4—N2—C3—N1 | 178.5 (2) | N3—O2—C7—C5 | 1.2 (3) |
| C4—N2—C3—S | 0.6 (3) | N3—O2—C7—C8 | −179.9 (2) |
| C1—S—C3—N1 | −0.9 (2) | C6—C5—C7—O2 | −1.2 (3) |
| C1—S—C3—N2 | 177.2 (2) | C4—C5—C7—O2 | −176.7 (2) |
| C3—N2—C4—O1 | 5.7 (4) | C6—C5—C7—C8 | −179.8 (3) |
| C3—N2—C4—C5 | −173.0 (2) | C4—C5—C7—C8 | 4.6 (5) |
| O1—C4—C5—C7 | 28.5 (4) |
Hydrogen-bond geometry (Å, º)
| D—H···A | D—H | H···A | D···A | D—H···A |
| N2—H2A···N1i | 0.86 | 2.14 | 2.970 (3) | 162 |
| C6—H6A···O1ii | 0.93 | 2.36 | 3.287 (4) | 171 |
Symmetry codes: (i) −x+1, −y, −z+1; (ii) −x+1, y−1/2, −z+1/2.
Footnotes
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: PV2631).
References
- Enraf–Nonius (1994). CAD-4 Software Enraf–Nonius, Delft, The Netherlands.
- Harms, K. & Wocadlo, S. (1995). XCAD4 University of Marburg, Germany.
- Huang, W. H., Yang, C. L., Lee, A. R. & Chiu, H. F. (2003). Chem. Pharm. Bull. 51, 313–314. [DOI] [PubMed]
- North, A. C. T., Phillips, D. C. & Mathews, F. S. (1968). Acta Cryst. A24, 351–359.
- Schattenkirchner, M. (2000). Immunopharmacology, 47, 291–298. [DOI] [PubMed]
- Shaw, J. J., Chen, B., Wooley, P., Palfey, B., Lee, A. R., Huang, W. H. & Zeng, D. (2011). Am. J. Biomed. Sci. 3, 218–227. [DOI] [PMC free article] [PubMed]
- Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. [DOI] [PubMed]
- Spek, A. L. (2009). Acta Cryst. D65, 148–155. [DOI] [PMC free article] [PubMed]
- Wang, D.-C., Huang, L.-C., Liu, H.-Q., Peng, Y.-R. & Song, J.-S. (2011). Acta Cryst. E67, o3207. [DOI] [PMC free article] [PubMed]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Crystal structure: contains datablock(s) I, New_Global_Publ_Block. DOI: 10.1107/S1600536813012105/pv2631sup1.cif
Structure factors: contains datablock(s) I. DOI: 10.1107/S1600536813012105/pv2631Isup2.hkl
Supplementary material file. DOI: 10.1107/S1600536813012105/pv2631Isup3.cml
Additional supplementary materials: crystallographic information; 3D view; checkCIF report

